$MCVT
Mill City Ventures III, Ltd Stock $mcvt

$mcvt Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165495424004122 Filed on April 02, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$471.6K	$802.0K	-$420.0K
YoY Change	-145.97%	-5.38%	-129.15%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$360.8K	$835.4K	$3.641M
YoY Change	-80.55%	67.16%	42.05%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$361.1K	$835.4K	$3.719M
YoY Change	-80.89%	67.16%	34.79%
Operating Profit
YoY Change
Interest Expense	$320.00	-$1.271M	$78.00K
YoY Change	-99.08%	52.76%	-60.18%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$547.8K	-$1.304M	-$1.620M
YoY Change	-156.05%	169.39%	-314.12%
Income Tax	$165.7K	-$416.6K	-$454.6K
% Of Pretax Income	30.25%
Net Earnings	$382.1K	-$887.7K	-$1.166M
YoY Change	-153.21%	180.7%	-301.74%
Net Earnings / Revenue	81.03%	-110.7%
Basic Earnings Per Share			-$0.18
Diluted Earnings Per Share	$0.06	-$0.14	-$0.19
COMMON SHARES
Basic Shares Outstanding	6.385M shares	6.385M shares	6.250M shares
Diluted Shares Outstanding	6.502M shares		6.366M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$504.7K	$376.0K	$376.0K
YoY Change	14.76%	-65.49%	-65.49%
Cash & Equivalents	$504.7K	$376.0K
Short-Term Investments
Other Short-Term Assets	$207.6K	$165.3K	$165.3K
YoY Change	-22.42%	235.84%	235.84%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.231M	$1.056M	$1.056M
YoY Change	-7.02%	-35.62%	-35.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.730K	$9.280K	$9.280K
YoY Change	-65.78%	-43.41%	-43.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$355.1K	$322.9K	$322.9K
YoY Change	-74.98%	-77.3%	-77.3%
Other Assets	$660.0K	$757.0K	$757.0K
YoY Change	43.17%	276.62%	276.62%
Total Long-Term Assets	$17.79M	$18.05M	$18.05M
YoY Change	-11.87%	6.65%	6.65%
TOTAL ASSETS
Total Short-Term Assets	$1.231M	$1.056M	$1.056M
Total Long-Term Assets	$17.79M	$18.05M	$18.05M
Total Assets	$19.02M	$19.11M	$19.11M
YoY Change	-11.57%	2.91%	2.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$36.50K	$71.70K	$71.70K
YoY Change	-59.91%	-47.48%	-47.48%
Accrued Expenses	$11.34K	$444.7K	$444.7K
YoY Change	2.44%	2585.57%	2585.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$47.84K	$516.4K	$516.4K
YoY Change	-53.15%	237.38%	237.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.84K	$516.4K	$516.4K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$47.83K	$516.4K	$516.4K
YoY Change	-98.35%	131.35%	131.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.160M	-$1.160M
YoY Change	0.0%	0.0%
Common Stock	$1.467M	$1.467M
YoY Change	-0.4%	11906.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.97M	$18.59M	$18.59M
YoY Change
Total Liabilities & Shareholders Equity	$19.02M	$19.11M	$19.11M
YoY Change	-11.57%	2.91%	2.91%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$382.1K	-$887.7K	-$1.166M
YoY Change	-153.21%	180.7%	-301.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$128.7K	-$586.8K	-$1.138M
YoY Change	-103.79%	-138.08%	-76.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	0.000	$424.0K
YoY Change	-100.0%	-100.0%	-89.51%
NET CHANGE
Cash From Operating Activities	$128.7K	-586.8K	-$1.138M
Cash From Investing Activities
Cash From Financing Activities	$0.00	0.000	$424.0K
Net Change In Cash	$128.7K	-586.8K	-$713.6K
YoY Change	-119.81%	-23.99%	-15.7%
FREE CASH FLOW
Cash From Operating Activities	$128.7K	-$586.8K	-$1.138M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.5965	pure
CY2023	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	-0.0225	pure
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001425355
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2023	mcvt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P1Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41472
CY2023	dei	Entity Registrant Name EntityRegistrantName	MILL CITY VENTURES III, LTD.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0316651
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1907 Wayzata Blvd
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	#205
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Wayzata
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	5539
CY2023	dei	City Area Code CityAreaCode	952
CY2023	dei	Local Phone Number LocalPhoneNumber	479-1923
CY2023	dei	Security12g Title Security12gTitle	Common stock, $0.001 par value per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	4354000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6385255	shares
CY2023	dei	Auditor Firm AuditorFirmId	542
CY2023	dei	Auditor Name AuditorName	Boulay PLLP
CY2023	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2023Q4	mcvt	Non Control Non Affiliate Investment At Cost NonControlNonAffiliateInvestmentAtCost	18577481	usd
CY2022Q4	mcvt	Non Control Non Affiliate Investment At Cost NonControlNonAffiliateInvestmentAtCost	17359804	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17284676	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	376024	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	165301	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	218440	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	264413	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	250879	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9283	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16398	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	757000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	201000	usd
CY2023Q4	us-gaap	Assets Assets	19106697	usd
CY2022Q4	us-gaap	Assets Assets	18734790	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	71702	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	136514	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	435449	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	640000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9283	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16562	usd
CY2023Q4	us-gaap	Deferred Income DeferredIncome	0	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	70154	usd
CY2023Q4	us-gaap	Liabilities Liabilities	516434	usd
CY2022Q4	us-gaap	Liabilities Liabilities	863230	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6385255	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6185255	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6385	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6185	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15473121	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15049321	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1460209	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2023Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Investment Loss AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss	-1052183	usd
CY2022Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Investment Loss AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss	-1086739	usd
CY2023Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions	5155200	usd
CY2022Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions	5713829	usd
CY2023Q4	mcvt	Stockholders Equity Unrealized Appreciation In Value Of Investments StockholdersEquityUnrealizedAppreciationInValueOfInvestments	-1292804	usd
CY2022Q4	mcvt	Stockholders Equity Unrealized Appreciation In Value Of Investments StockholdersEquityUnrealizedAppreciationInValueOfInvestments	-651371	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18590263	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19106697	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18734790	usd
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.91
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.89
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	3298635	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	4199453	usd
CY2023	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	3298635	usd
CY2022	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	4199453	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	761525	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1592218	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1848393	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	941590	usd
CY2023	us-gaap	General Insurance Expense GeneralInsuranceExpense	108039	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	111110	usd
CY2023	us-gaap	Occupancy Net OccupancyNet	68421	usd
CY2022	us-gaap	Occupancy Net OccupancyNet	73146	usd
CY2023	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	772968	usd
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	417073	usd
CY2023	us-gaap	Interest Expense InterestExpense	78000	usd
CY2022	us-gaap	Interest Expense InterestExpense	195893	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	81287	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	67847	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3718633	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	3398877	usd
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	-419998	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	800576	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-558629	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	133019	usd
CY2023	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-641433	usd
CY2022	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-816989	usd
CY2023	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-1200062	usd
CY2022	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-683970	usd
CY2023	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	-1620060	usd
CY2022	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	116606	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-454554	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9648	usd
CY2023	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	-1165506	usd
CY2022	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	106958	usd
CY2023	mcvt	Basic And Diluted Earning Per Share BasicAndDilutedEarningPerShare	-0.18
CY2022	mcvt	Basic And Diluted Earning Per Share BasicAndDilutedEarningPerShare	0.02
CY2023	mcvt	Basic And Diluted Weighted Average Shares Outstanding BasicAndDilutedWeightedAverageSharesOutstanding	6249913	shares
CY2022	mcvt	Basic And Diluted Weighted Average Shares Outstanding BasicAndDilutedWeightedAverageSharesOutstanding	5333028	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1460209	usd
CY2023	mcvt	Exercise Of Stock Options Amount ExerciseOfStockOptionsAmount	424000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	34556	usd
CY2023	mcvt	Undistributed Net Realized Loss On Investment Transactions UndistributedNetRealizedLossOnInvestmentTransactions	-558629	usd
CY2023	mcvt	Depreciation In Value Of Investments DepreciationInValueOfInvestments	-641433	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18590263	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13414049	usd
CY2022	mcvt	Common Shares Issued In Public Offering Net Of Underwriting Costs And Warrants Amount CommonSharesIssuedInPublicOfferingNetOfUnderwritingCostsAndWarrantsAmount	3840622	usd
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	201173	usd
CY2022	mcvt	Common Shares Issued In Reverse Stock Split Rounding Amount CommonSharesIssuedInReverseStockSplitRoundingAmount	0	usd
CY2022	mcvt	Common Shares Issued In Stock Based Compensation Amount CommonSharesIssuedInStockBasedCompensationAmount	149315	usd
CY2022	mcvt	Common Shares Issued In Consideration For Expense Payment Amount CommonSharesIssuedInConsiderationForExpensePaymentAmount	159443	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	790928	usd
CY2022	mcvt	Undistributed Net Realized Gain On Investment Transactions UndistributedNetRealizedGainOnInvestmentTransactions	133019	usd
CY2022	mcvt	Depreciation In Value Of Investments DepreciationInValueOfInvestments	-816989	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
CY2023	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	-1165506	usd
CY2022	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	106958	usd
CY2023	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-641433	usd
CY2022	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-816989	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-558629	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	133019	usd
CY2023	mcvt	Purchases Of Investments PurchasesOfInvestments	-12900500	usd
CY2022	mcvt	Purchases Of Investments PurchasesOfInvestments	-23558458	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	11124194	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	20264731	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1460209	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-556000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-246000	usd
CY2023	mcvt	Stock Based Compensation To Employees And Vendors StockBasedCompensationToEmployeesAndVendors	0	usd
CY2022	mcvt	Stock Based Compensation To Employees And Vendors StockBasedCompensationToEmployeesAndVendors	308758	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	60254	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-146180	usd
CY2023	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-13534	usd
CY2022	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	73471	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1900000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-276642	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	723294	usd
CY2023	mcvt	Increase Decrease In Deferred Interest Income IncreaseDecreaseInDeferredInterestIncome	-70154	usd
CY2022	mcvt	Increase Decrease In Deferred Interest Income IncreaseDecreaseInDeferredInterestIncome	70154	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1269000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1137617	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4888302	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4041795	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	424000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2750000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9793800	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2750000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	9793800	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	424000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4041795	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-713617	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-846507	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1936148	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	376024	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	428948	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	78000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	195894	usd
CY2023Q4	mcvt	Total Investments Cost At Fair Value TotalInvestmentsCostAtFairValue	18577481	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17284676	usd
CY2023	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.9297	pure
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	376024	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	376024	usd
CY2023	mcvt	Cash And Cash Equivalents Percent Of Net Assets CashAndCashEquivalentsPercentOfNetAssets	0.0202	pure
CY2023Q4	mcvt	Investments And Cash Cost InvestmentsAndCashCost	18953505	usd
CY2023Q4	mcvt	Investments And Cash Fair Value InvestmentsAndCashFairValue	17660700	usd
CY2023	mcvt	Investments And Cash Percentage Of Net Assets InvestmentsAndCashPercentageOfNetAssets	0.9499	pure
CY2022Q4	mcvt	Total Investments Cost At Fair Value TotalInvestmentsCostAtFairValue	17359804	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2022	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.9350	pure
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1089641	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1089641	usd
CY2022	mcvt	Cash And Cash Equivalents Percent Of Net Assets CashAndCashEquivalentsPercentOfNetAssets	0.0610	pure
CY2022Q4	mcvt	Investments And Cash Cost InvestmentsAndCashCost	18449445	usd
CY2022Q4	mcvt	Investments And Cash Fair Value InvestmentsAndCashFairValue	17798073	usd
CY2022	mcvt	Investments And Cash Percentage Of Net Assets InvestmentsAndCashPercentageOfNetAssets	0.9960	pure
CY2023	mcvt	Maximuum Percentage Total Assets Of Investment Securities MaximuumPercentageTotalAssetsOfInvestmentSecurities	0.40	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5pt; text-align:justify;"><strong><em>Use of estimates: </em></strong>The preparation of financial statements in conformity with GAAP requires management and our independent board members to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. For more information, see the “Valuation of portfolio investments” caption below, and “Note 7 – Fair Value of Financial Instruments” below. The Company presents its financial statements as an investment company following accounting and reporting guidance in ASC 946.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5pt; text-align:justify;">The presentation of certain items in the financial statements for the year ended December 31, 2022, has been changed to conform to the classifications used in 2023. These reclassifications had no effect on shareholders’ equity or net increase in net assets as previously recorded.</p>
CY2023	mcvt	Investment Company Net Increase Decrease In Net Assets From Operations InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations	-1165506	usd
CY2022	mcvt	Investment Company Net Increase Decrease In Net Assets From Operations InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations	106958	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6249913	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5333028	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	870000	shares
CY2023Q4	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	670000	shares
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045	pure
CY2023	mcvt	Rent Expense RentExpense	68421	usd
CY2022	mcvt	Rent Expense RentExpense	73146	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	21975	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	21291	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	19572	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	18325	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	26874	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	33530	usd
CY2023	us-gaap	Lease Cost LeaseCost	68421	usd
CY2022	us-gaap	Lease Cost LeaseCost	73146	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9283	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16398	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9283	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16562	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9283	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16562	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	16675	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9353	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9353	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	16675	usd
CY2023Q4	mcvt	Operating Lease Interest OperatingLeaseInterest	-70	usd
CY2022Q4	mcvt	Operating Lease Interest OperatingLeaseInterest	-113	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9283	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16562	usd
CY2023Q4	mcvt	Operating Cash Outflow From Operating Leases OperatingCashOutflowFromOperatingLeases	69743	usd
CY2022Q4	mcvt	Operating Cash Outflow From Operating Leases OperatingCashOutflowFromOperatingLeases	75146	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6385255	shares
CY2022Q3	mcvt	Stockholders Equity Reverse Stock StockholdersEquityReverseStock	common shares on a 1-for-2.25 basis such that every 2.25 shares of common stock issued and outstanding on that date were combined into one share of common stock
CY2022Q3	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	111111111	shares
CY2022Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1250000	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.00
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5000000	usd
CY2022Q3	mcvt	Amount Received From Issue Of Shares After Expenses AmountReceivedFromIssueOfSharesAfterExpenses	4041000	usd
CY2023	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	75000	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.00
CY2023Q4	us-gaap	Fair Value Concentration Of Risk Guarantees FairValueConcentrationOfRiskGuarantees	201173	usd
CY2023Q4	mcvt	Common Stock Issued CommonStockIssued	200000	shares
CY2022Q4	mcvt	Common Stock Issued CommonStockIssued	1389516	shares
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	18577481	usd
CY2023	mcvt	Investment And Loans Amortized Cost InvestmentAndLoansAmortizedCost	1.000	pure
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17284676	usd
CY2023	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	17359804	usd
CY2022	mcvt	Investment And Loans Amortized Cost InvestmentAndLoansAmortizedCost	1.000	pure
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2022	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17284676	usd
CY2023	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2022	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2023Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	16961766	usd
CY2023Q4	mcvt	Preferred Stock PreferredStock	265000	usd
CY2023Q4	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	47910	usd
CY2023Q4	mcvt	Fair Value Warrants FairValueWarrants	0	usd
CY2023Q4	mcvt	Fair Value Other Equity FairValueOtherEquity	10000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17284676	usd
CY2022Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	15285932	usd
CY2022Q4	mcvt	Preferred Stock PreferredStock	1200000	usd
CY2022Q4	mcvt	Fair Value Warrants FairValueWarrants	0	usd
CY2022Q4	mcvt	Fair Value Other Equity FairValueOtherEquity	222500	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	870000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.11
CY2023	mcvt	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGross	-200000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.12
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	670000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.11
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	670000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.11
CY2023	mcvt	Weighted Average Grant Date Fair Value For Options Granted During The Period WeightedAverageGrantDateFairValueForOptionsGrantedDuringThePeriod	1460209	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1460209	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0388	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9000	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	23750	usd
CY2022	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	14063	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	83402	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	268803	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	18044	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-13155	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-556000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-246000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-454554	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9648	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-431776	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	97503	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-1866	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	450	usd
CY2023	mcvt	Income Tax Reconciliation Prior Year Over IncomeTaxReconciliationPriorYearOver	93702	usd
CY2023	mcvt	Effective Income Tax Rate Reconciliation Provision To Return Reconciliation Amount EffectiveIncomeTaxRateReconciliationProvisionToReturnReconciliationAmount	-110457	usd
CY2022	mcvt	Effective Income Tax Rate Reconciliation Provision To Return Reconciliation Amount EffectiveIncomeTaxRateReconciliationProvisionToReturnReconciliationAmount	-18536	usd
CY2023	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	0	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-71856	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4157	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2087	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-454554	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9648	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	757000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	201000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	343886	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	156590	usd
CY2023Q4	mcvt	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	1619	usd
CY2022Q4	mcvt	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	1781	usd
CY2023Q4	mcvt	Deferred Tax Assets Tax Credit Carryforwards Research Developments And Foreign DeferredTaxAssetsTaxCreditCarryforwardsResearchDevelopmentsAndForeign	40820	usd
CY2022Q4	mcvt	Deferred Tax Assets Tax Credit Carryforwards Research Developments And Foreign DeferredTaxAssetsTaxCreditCarryforwardsResearchDevelopmentsAndForeign	43828	usd
CY2023Q4	mcvt	Lease Liability LeaseLiability	0	usd
CY2022Q4	mcvt	Lease Liability LeaseLiability	-39	usd
CY2023Q4	mcvt	Deferred Tax Stock Options DeferredTaxStockOptions	275632	usd
CY2022Q4	mcvt	Deferred Tax Stock Options DeferredTaxStockOptions	0	usd
CY2023Q4	mcvt	Deferred Tax Acquistion Cost DeferredTaxAcquistionCost	30402	usd
CY2023Q4	mcvt	Deferrd Tax Accrued Bonuses DeferrdTaxAccruedBonuses	66500	usd
CY2022Q4	mcvt	Deferrd Tax Accrued Bonuses DeferrdTaxAccruedBonuses	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1859	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1160	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	757000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	201000	usd
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.80
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.44
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.05
CY2018Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.30
CY2023	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.07
CY2022	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.13
CY2021	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.27
CY2020	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.11
CY2019	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.14
CY2023	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.19
CY2022	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.11
CY2021	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.54
CY2020	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.41
CY2019	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.00
CY2023	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	0.07
CY2022	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	0.00
CY2021	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	-0.23
CY2020	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	-0.05
CY2019	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	0.00
CY2023	mcvt	Issuance Of Common Stock IssuanceOfCommonStock	0.07
CY2022	mcvt	Issuance Of Common Stock IssuanceOfCommonStock	0.00
CY2021	mcvt	Issuance Of Common Stock IssuanceOfCommonStock	0.00
CY2019	mcvt	Issuance Of Common Stock IssuanceOfCommonStock	0.00
CY2020	mcvt	Issuance Of Common Stock IssuanceOfCommonStock	0.00
CY2023	mcvt	Investment Company Stock Based Compensation InvestmentCompanyStockBasedCompensation	0.23
CY2022	mcvt	Investment Company Stock Based Compensation InvestmentCompanyStockBasedCompensation	0.05
CY2021	mcvt	Investment Company Stock Based Compensation InvestmentCompanyStockBasedCompensation	0.00
CY2020	mcvt	Investment Company Stock Based Compensation InvestmentCompanyStockBasedCompensation	-0.02
CY2019	mcvt	Investment Company Stock Based Compensation InvestmentCompanyStockBasedCompensation	0.00
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2020	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2019	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2023	us-gaap	Change In Reporting Entity Earnings Per Share Basic ChangeInReportingEntityEarningsPerShareBasic	-0.09
CY2022	us-gaap	Change In Reporting Entity Earnings Per Share Basic ChangeInReportingEntityEarningsPerShareBasic	0.02
CY2021	us-gaap	Change In Reporting Entity Earnings Per Share Basic ChangeInReportingEntityEarningsPerShareBasic	0.00
CY2020	us-gaap	Change In Reporting Entity Earnings Per Share Basic ChangeInReportingEntityEarningsPerShareBasic	0.00
CY2019	us-gaap	Change In Reporting Entity Earnings Per Share Basic ChangeInReportingEntityEarningsPerShareBasic	0.00
CY2023	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00
CY2022	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00
CY2021	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.22
CY2020	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.11
CY2019	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.11
CY2023Q4	mcvt	Financial Highlights Net Asset Value At End Of Period FinancialHighlightsNetAssetValueAtEndOfPeriod	2.91
CY2022Q4	mcvt	Financial Highlights Net Asset Value At End Of Period FinancialHighlightsNetAssetValueAtEndOfPeriod	2.89
CY2021Q4	mcvt	Financial Highlights Net Asset Value At End Of Period FinancialHighlightsNetAssetValueAtEndOfPeriod	2.80
CY2020Q4	mcvt	Financial Highlights Net Asset Value At End Of Period FinancialHighlightsNetAssetValueAtEndOfPeriod	2.44
CY2019Q4	mcvt	Financial Highlights Net Asset Value At End Of Period FinancialHighlightsNetAssetValueAtEndOfPeriod	2.05
CY2023Q4	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.75
CY2022Q4	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.70
CY2021Q4	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.95
CY2020Q4	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	1.40
CY2019Q4	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	0.36
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4795739	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4793739	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4918845	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6366481	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5333028	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4795242	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4830691	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4918845	shares
CY2023Q4	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	18590263	usd
CY2022Q4	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	17871560	usd
CY2021Q4	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	13414049	usd
CY2020Q4	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	11640887	usd
CY2019Q4	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	10068533	usd
CY2023	mcvt	Average Net Assets AverageNetAssets	18647600	usd
CY2022	mcvt	Average Net Assets AverageNetAssets	15639394	usd
CY2021	mcvt	Average Net Assets AverageNetAssets	13155207	usd
CY2020	mcvt	Average Net Assets AverageNetAssets	10504563	usd
CY2019	mcvt	Average Net Assets AverageNetAssets	11473535	usd
CY2023	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0727	pure
CY2022	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0143	pure
CY2021	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.2407	pure
CY2020	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.2308	pure
CY2019	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0588	pure
CY2022	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	1.2957	pure
CY2021	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	1.6867	pure
CY2020	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.6111	pure
CY2019	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.0763	pure
CY2023	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1994	pure
CY2022	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.2173	pure
CY2021	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1030	pure
CY2020	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0716	pure
CY2019	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0727	pure
CY2022	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0512	pure
CY2021	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0989	pure
CY2020	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0535	pure
CY2019	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0586	pure
CY2023	mcvt	Investment Company Investment Income Loss Ratio Net InvestmentCompanyInvestmentIncomeLossRatioNet	-0.0300	pure
CY2022	mcvt	Investment Company Investment Income Loss Ratio Net InvestmentCompanyInvestmentIncomeLossRatioNet	0.0085	pure
CY2021	mcvt	Investment Company Investment Income Loss Ratio Net InvestmentCompanyInvestmentIncomeLossRatioNet	0.3130	pure
CY2020	mcvt	Investment Company Investment Income Loss Ratio Net InvestmentCompanyInvestmentIncomeLossRatioNet	0.0005	pure
CY2019	mcvt	Investment Company Investment Income Loss Ratio Net InvestmentCompanyInvestmentIncomeLossRatioNet	0.2835	pure

Files In Submission

Name	View Source	Status
0001654954-24-004122-index-headers.html	Edgar Link	pending
0001654954-24-004122-index.html	Edgar Link	pending
0001654954-24-004122.txt	Edgar Link	pending
0001654954-24-004122-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mcvt-20231231.xsd	Edgar Link	pending
mcvt_10k.htm	Edgar Link	pending
mcvt_ex311.htm	Edgar Link	pending
mcvt_ex312.htm	Edgar Link	pending
mcvt_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mcvt-20231231_cal.xml	Edgar Link	unprocessable
mcvt-20231231_def.xml	Edgar Link	unprocessable
mcvt-20231231_lab.xml	Edgar Link	unprocessable
mcvt-20231231_pre.xml	Edgar Link	unprocessable
mcvt_10k_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MCVT
Mill City Ventures III, Ltd Stock $mcvt

2024 Q1 Form 10-K Financial Statement

#000165495424004122 Filed on April 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT Mill City Ventures III, Ltd Stock $mcvt

2024 Q1 Form 10-K Financial Statement

#000165495424004122 Filed on April 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT
Mill City Ventures III, Ltd Stock $mcvt